|
Timothy-Franson
Timothy R. Franson, M.D.
Timothy R. Franson, M.D., will be retiring 6/1/08 from the position of Vice President of Global Regulatory Affairs at Lilly Research Laboratories. He joined Eli Lilly and Company in 1986, where he has previously served as Director of Anti-Infectives; Group Medical Director, Europe (based in the United Kingdom); Executive Director of Health Economics Research and Decision Sciences, Executive Director of Regulatory Affairs responsible for North American Regulatory, Chemistry Manufacturing Control, Planning & Global Operations (safety, labeling, medical information, registration and submissions) and from 1997-2003, Vice President of Clinical Research and Regulatory Affairs-US. During his time in regulatory affairs, he has been directly responsible for Lilly’s FDA submissions (NDAs, supplements) since 1995, involving over 20 major submission reviews and approvals, and is now responsible for both Global Regulatory Affairs and Global Patient Safety organizations. In 2002, he received the Lilly Chairman's Ovation Award. He is also an Assistant Professor of Medicine at Indiana University School of Medicine.
Franson received his undergraduate degree in Pharmacy (B.S. Pharm, honors) at Drake University, his M.D. degree (James Scholar, with honors) at the University of Illinois, and completed internal medicine training at the University of Iowa, followed by a fellowship in Infectious Diseases and Epidemiology at the Medical College of Wisconsin. He is Board Certified in Internal Medicine and Infectious Diseases. He was Assistant Professor of Medicine and Hospital Epidemiologist at the Medical College of Wisconsin where he was a NIH funded investigator and a member of the State of Wisconsin’s Governors Task Force on AIDS.
Dr. Franson has authored over 50 articles and one text in the fields of infectious disease, epidemiology, pharmacoeconomics and antibiotic utilization. He has served as chair of the Clinical Steering Committee and as a member of the Regulatory Affairs Coordinating Committee of the Pharmaceutical Research and Manufacturers’ Association (PhRMA) and until recently, chaired PhRMAs FDA Committee Staff Work Group (2000-2008) and previously chaired their GMP Steering Committee. He was co-chair of the joint FDA-industry working group addressing clinical aspects of the FDA Modernization Act of 1997, including the Prescription Drug User Fee Act (PDUFA) renewal; and from 2000-2003 he co-chaired the overall industry-FDA committees for PDUFA-3 renewal and has testified at several congressional hearings representing industry. He also co-chaired an FDA-industry safety interventions working group, was a member of the AAMC-PhRMA Clinical Trials Forum and is a member of the Regulatory Advisory Board for the Centre for Medicines Research International. He previously served on the Board of Directors for the National Patient Safety Foundation (NPSF, 2001-2006) and on the Editorial Advisory Board for FDA Advertising & Promotional Manual (1997-2005). Franson is now a member of the Board of Directors of the Villages of Indiana child welfare services (immediate past Chair), Little Red Door Cancer Agency Board of Directors, the Indiana State Museum Foundation, as well as the Board of Trustees of Xavier University of Louisiana and also serves on the American Association of Colleges of Pharmacy Professional Education Advisory Council. He is a Fellow of the Infectious Diseases Society of America, a Fellow of the American College of Physicians, served on the European Working Party for Antimicrobial Trial Guidelines, and was principal respondent for industry at the FDA Advisory Committee review of the FDA/IDSA Antimicrobial Trial Guidelines project.
Franson previously served on Drake University’s Task Force on the College of Pharmacy and Health Sciences and Dean's Council and is currently a member of the College of Pharmacy Dean's Advisory Board for Auburn University. He has also been active in his community’s schools, serving previously as Chair of the School District Educational Master Plan Committee, and as a member of the Superintendent’s Advisory Board, and of the Athletic Booster Club Board. |
|
Donate
Please consider a tax-deductible contribution to CMPI. Your support is appreciated.
|
